Nervosave Therapeutics
NVO-801 / Neuropathic pain

A local approach to persistent nerve pain

Exploring long-lasting, nerve-targeted therapeutic activity for severe or refractory localized neuropathic pain.

Visual representing neuropathic pain
Program overview

The unmet need

Neuropathic pain can be persistent and difficult to manage. Systemic treatments may not provide adequate relief for all patients and may cause unwanted effects.

Our investigational approach

NVO-801 is being developed around perineural AAV delivery of a locally acting therapeutic payload. The goal is to modulate pain signaling near a selected peripheral nerve while minimizing systemic exposure.

Development status

NVO-801 remains investigational. Preclinical proof-of-concept work informs further research, but durable analgesic efficacy and safety have not been established in human patients.

At a glance

Program focus

  • Localized pain
  • Perineural AAV platform
  • Long-term activity is a goal
  • Preclinical-stage development

Investigational research program. Preclinical observations do not demonstrate clinical safety or efficacy.

Collaborate with Nervosave

Advance nerve health innovation

We welcome conversations with scientific, clinical and strategic partners.